Quality control throughout cell therapy research and design is critical to ensuring safety and efficacy. Cell therapy products are at risk of becoming contaminated with bacteria, viruses, or allergenic agents. Defining the parameters of cell quality and routinely assessing cell therapy products is key to therapeutic success.
In this webinar, brought to you by The Scientist and sponsored by Sartorius, Steven Keizer, an expert in designing quality systems to fit the pharmaceutical industry, and Stephen Sullivan, an expert in establishing clinical-grade induced pluripotent stem cells, will discuss how best to define and assess cell quality for therapeutic purposes.
Topics to be covered
- Cell quality in research and therapeutic applications
- Quality guidelines for induced pluripotent stem cells to be used for therapeutic development
Meet the Speakers:
Steven Keizer, PhD, MBA
Director of Quality
CCRM (Centre for Commercialization of Regenerative Medicine)
Stephen Sullivan, PhD, MBA, FRSM
International Liaison Officer
GAiT (Global Alliance for iPSC Therapies)